Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1976 Dec;58(4):593–598. doi: 10.1111/j.1476-5381.1976.tb08628.x

Centrally induced hypotension and bradycardia after administration of alpha-methylnoradrenaline into the area of the nucleus tractus solitarii of the rat.

W De Jong, F P Nijkamp
PMCID: PMC1667478  PMID: 793669

Abstract

1 In anaesthetized rats, bilateral injections of alpha-methylnoradrenaline, noradrenaline or adrenaline into the area of the nucleus tractus solitarii (NTS) of the brain stem caused dose-dependent decreases of systemic arterial blood pressure and heart rate. The effects of alpha-methylnoradrenaline were most pronounced and lasted longest. 2 The cardiovascular effects of alpha-methylnoradrenaline appeared to be restricted to the medio-caudal part of the NTS. 3 Prior administration of the alpha-adrenoceptor blocking agent, phentolamine, reversed the fall in blood pressure and heart rate induced by alpha-methylnoradrenaline into an increase. 4 Systemic administration of atropine combined with vagotomy potentiated the inhibitory effects of alpha-methylnoradrenaline on the cardiovascular system.

Full text

PDF
593

Images in this article

595Figure 2
on p.595

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhargava K. P., Mishra N., Tangri K. K. An analysis of central adrenoceptors for control of cardiovascular function. Br J Pharmacol. 1972 Aug;45(4):596–602. doi: 10.1111/j.1476-5381.1972.tb08117.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Day M. D., Roach A. G. Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats. Br J Pharmacol. 1974 Jul;51(3):325–333. doi: 10.1111/j.1476-5381.1974.tb10666.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Day M. D., Roach A. G., Whiting R. L. The mechanism of the antihypertensive action of -methyldopa in hypertensive rats. Eur J Pharmacol. 1973 Mar;21(3):271–280. doi: 10.1016/0014-2999(73)90126-x. [DOI] [PubMed] [Google Scholar]
  4. De Jong W. Noradrenaline: central inhibitory control of blood pressure and heart rate. Eur J Pharmacol. 1974 Nov;29(1):179–181. doi: 10.1016/0014-2999(74)90188-5. [DOI] [PubMed] [Google Scholar]
  5. FUXE K. EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM. Acta Physiol Scand Suppl. 1965:SUPPL 247–247:37+. [PubMed] [Google Scholar]
  6. Finch L., Haeusler G. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat. Br J Pharmacol. 1973 Feb;47(2):217–228. doi: 10.1111/j.1476-5381.1973.tb08319.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Finch L., Hersom A., Hicks P. Studies on the hypotensive action of alpha-methyldopamine. Br J Pharmacol. 1975 Aug;54(4):445–451. doi: 10.1111/j.1476-5381.1975.tb07590.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Heise A., Kroneberg G. -Sympathetic receptor stimulation in the brain and hypotensive activity of -methyldopa. Eur J Pharmacol. 1972 Feb;17(2):315–317. doi: 10.1016/0014-2999(72)90180-x. [DOI] [PubMed] [Google Scholar]
  9. Henning M. Central sympathetic transmitters and hypertension. Clin Sci Mol Med Suppl. 1975 Jun;2:195s–203s. doi: 10.1042/cs048195s. [DOI] [PubMed] [Google Scholar]
  10. Henning M., Rubenson A. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline. J Pharm Pharmacol. 1971 Jun;23(6):407–411. doi: 10.1111/j.2042-7158.1971.tb08671.x. [DOI] [PubMed] [Google Scholar]
  11. Henning M., van Zwieten P. A. Central hypotensive effect of alpha-methyldopa. J Pharm Pharmacol. 1968 Jun;20(6):409–417. doi: 10.1111/j.2042-7158.1968.tb09776.x. [DOI] [PubMed] [Google Scholar]
  12. Lang W. J., Rush M. L. Cardiovascular responses to injections of cholinomimetic drugs into the cerebral ventricles of unanaesthetized dogs. Br J Pharmacol. 1973 Feb;47(2):196–205. doi: 10.1111/j.1476-5381.1973.tb08317.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nijkamp F. P., De Jong W. alpha-Methylnoradrenaline induced hypotension and bradycardia after administration into the area of the nucleus tractus solitarii. Eur J Pharmacol. 1975 Jun-Jul;32(02):361–364. doi: 10.1016/0014-2999(75)90305-2. [DOI] [PubMed] [Google Scholar]
  14. Nijkamp F. P., Ezer J., De Jong W. Central inhibitory effect of alpha-methyldopa on blood pressure, heart rate and body temperature of renal hypertensive rats. Eur J Pharmacol. 1975 Apr;31(2):243–249. doi: 10.1016/0014-2999(75)90046-1. [DOI] [PubMed] [Google Scholar]
  15. Palkovits M., Jacobowitz D. M. Topographic atlas of catecholamine and acetylcholinesterase-containing neurons in the rat brain. II. Hindbrain (mesencephalon, rhombencephalon). J Comp Neurol. 1974 Sep 1;157(1):29–42. doi: 10.1002/cne.901570104. [DOI] [PubMed] [Google Scholar]
  16. Toda N., Matsuda Y., Shimamoto K. Cardiovascular effects of sympathomimetic amines injected into the cerebral ventricles of rabbits. Int J Neuropharmacol. 1969 Sep;8(5):451–461. doi: 10.1016/0028-3908(69)90061-6. [DOI] [PubMed] [Google Scholar]
  17. de Jong W., Nijkamp F. P., Bohus B. Role of noradrenaline and serotonin in the central control of blood pressure in normotensive and spontaneously hypertensive rats. Arch Int Pharmacodyn Ther. 1975 Feb;213(2):272–284. [PubMed] [Google Scholar]
  18. de Jong W., Zandberg P., Bohus B. Central inhibitory noradrenergic cardiovascular control. Prog Brain Res. 1975;42:285–298. doi: 10.1016/S0079-6123(08)63671-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES